<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34638875</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>27</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>27</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1422-0067</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>22</Volume>
            <Issue>19</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Sep</Month>
              <Day>29</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of molecular sciences</Title>
          <ISOAbbreviation>Int J Mol Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Combination of PD98059 and TGF-β1 Efficiently Differentiates Human Urine-Derived Stem Cells into Smooth Muscle Cells.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">10532</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms221910532</ELocationID>
        <Abstract>
          <AbstractText>Pluripotent adult stem cells have potential applications in cell therapy and tissue engineering. Urine-derived stem cells (UDSCs) differentiate into various cell types. Here, we attempted to differentiate human UDSCs (hUDSCs) into smooth muscle cells (SMCs) using transforming growth factor-beta 1 (TGF-β1) and/or PD98059, an extracellular signal-regulated kinase (ERK) inhibitor. Both quantitative polymerase chain reaction (qPCR) and Western blot analysis showed that the expression of messenger ribonucleic acid (mRNA) and proteins for alpha-smooth muscle actin (α-SMA), calponin (CNN1), and smooth muscle myosin heavy chain (SM-MHC), which are specific markers for SMCs, increased on day 9 after differentiation and again on day 14. The differentiated cells from human UDSCs (hUDSCs) with a combination of TGF-β1 and PD98059 showed the highest expression of SMC marker proteins. Immunocytochemical staining performed to assess the molecular expression revealed CNN and α-SMA colocalizing in the cytoplasm. The cells that differentiated from hUDSCs with a combination of TGF-β1 and PD98059 showed the strongest expression for CNN1, α-SMA, and SM-MHC. Functional testing of the differentiated cells revealed a stronger contractile capacity for the cells differentiated with a combination of PD98059 and TGF-β1 than those differentiated with a single factor. These results suggest the combination of PD98059 and TGF-β1 to be a more effective differentiation method and that differentiated SMCs could be used for restoring the functions of the sphincter muscle or bladder.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hwang</LastName>
            <ForeName>Yongha</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>College of Pharmacy and Gachon Institute of Pharmaceutical Science, Gachon University, Incheon 21999, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cha</LastName>
            <ForeName>Seon-Heui</ForeName>
            <Initials>SH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Marine Bio and Medical Sciences, Hanseo University, Seonsan-si 31962, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Donghee</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>College of Pharmacy and Gachon Institute of Pharmaceutical Science, Gachon University, Incheon 21999, Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon 21936, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jun</LastName>
            <ForeName>Hee-Sook</ForeName>
            <Initials>HS</Initials>
            <Identifier Source="ORCID">0000-0002-1166-4932</Identifier>
            <AffiliationInfo>
              <Affiliation>College of Pharmacy and Gachon Institute of Pharmaceutical Science, Gachon University, Incheon 21999, Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon 21936, Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Gachon Medical Research Institute, Gil Hospital, Incheon 21999, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>Grant number: HI14C1135</GrantID>
            <Agency>Korea Health Industry Development Institute</Agency>
            <Country>Republic of Korea</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>09</Month>
          <Day>29</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Int J Mol Sci</MedlineTA>
        <NlmUniqueID>101092791</NlmUniqueID>
        <ISSNLinking>1422-0067</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D005419">Flavonoids</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C508960">TGFB1 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053773">Transforming Growth Factor beta1</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>SJE1IO5E3I</RegistryNumber>
          <NameOfSubstance UI="C093973">2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005419" MajorTopicYN="N">Flavonoids</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D032342" MajorTopicYN="Y">Muscle Cells</DescriptorName>
          <QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013234" MajorTopicYN="Y">Stem Cells</DescriptorName>
          <QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053773" MajorTopicYN="N">Transforming Growth Factor beta1</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014556" MajorTopicYN="N">Urine</DescriptorName>
          <QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">diabetes</Keyword>
        <Keyword MajorTopicYN="N">differentiation of insulin producing cell</Keyword>
        <Keyword MajorTopicYN="N">pluripotent adult stem cells</Keyword>
        <Keyword MajorTopicYN="N">urine-derived stem cell</Keyword>
      </KeywordList>
      <CoiStatement>The authors have no competing interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>13</Day>
          <Hour>1</Hour>
          <Minute>3</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34638875</ArticleId>
        <ArticleId IdType="pmc">PMC8508912</ArticleId>
        <ArticleId IdType="doi">10.3390/ijms221910532</ArticleId>
        <ArticleId IdType="pii">ijms221910532</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Charalambous S.T.A. Impact of urinary incontinence on quality of life. Pelviperineology. 2009;28:51–53.</Citation>
        </Reference>
        <Reference>
          <Citation>Luber K.M. The definition, prevalence, and risk factors for stress urinary incontinence. Rev. Urol. 2004;6((Suppl. 3)):S3–S9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1472862</ArticleId>
            <ArticleId IdType="pubmed">16985863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rovner E.S., Wein A.J. Treatment options for stress urinary incontinence. Rev. Urol. 2004;6((Suppl. 3)):S29–S47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1472859</ArticleId>
            <ArticleId IdType="pubmed">16985862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nilsson C.G., Kuuva N. The tension-free vaginal tape procedure is successful in the majority of women with indications for surgical treatment of urinary stress incontinence. BJOG Int. J. Obstet. Gynaecol. 2001;108:414–419. doi: 10.1111/j.1471-0528.2001.00092.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1471-0528.2001.00092.x</ArticleId>
            <ArticleId IdType="pubmed">11305550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wallner C., Dabhoiwala N.F., DeRuiter M.C., Lamers W.H. The anatomical components of urinary continence. Eur. Urol. 2009;55:932–944. doi: 10.1016/j.eururo.2008.08.032.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.eururo.2008.08.032</ArticleId>
            <ArticleId IdType="pubmed">18755535</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y., McNeill E., Tian H., Soker S., Andersson K.E., Yoo J.J., Atala A. Urine derived cells are a potential source for urological tissue reconstruction. J. Urol. 2008;180:2226–2233. doi: 10.1016/j.juro.2008.07.023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.juro.2008.07.023</ArticleId>
            <ArticleId IdType="pubmed">18804817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nickel J.C. Lower urinary tract symptoms associated with prostatitis. Can. Urol. Assoc. J. 2012;6:S133–S135. doi: 10.5489/cuaj.1468.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5489/cuaj.1468</ArticleId>
            <ArticleId IdType="pmc">PMC3481939</ArticleId>
            <ArticleId IdType="pubmed">23092777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang D., Wei G., Li P., Zhou X., Zhang Y. Urine-derived stem cells: A novel and versatile progenitor source for cell-based therapy and regenerative medicine. Genes Dis. 2014;1:8–17. doi: 10.1016/j.gendis.2014.07.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.gendis.2014.07.001</ArticleId>
            <ArticleId IdType="pmc">PMC4234168</ArticleId>
            <ArticleId IdType="pubmed">25411659</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krause D.S., Theise N.D., Collector M.I., Henegariu O., Hwang S., Gardner R., Neutzel S., Sharkis S.J. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 2001;105:369–377. doi: 10.1016/S0092-8674(01)00328-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0092-8674(01)00328-2</ArticleId>
            <ArticleId IdType="pubmed">11348593</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Covas D.T., Panepucci R.A., Fontes A.M., Silva W.A., Jr., Orellana M.D., Freitas M.C., Neder L., Santos A.R., Peres L.C., Jamur M.C., et al.  Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. Exp. Hematol. 2008;36:642–654. doi: 10.1016/j.exphem.2007.12.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.exphem.2007.12.015</ArticleId>
            <ArticleId IdType="pubmed">18295964</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karaoz E., Okcu A., Unal Z.S., Subasi C., Saglam O., Duruksu G. Adipose tissue-derived mesenchymal stromal cells efficiently differentiate into insulin-producing cells in pancreatic islet microenvironment both in vitro and in vivo. Cytotherapy. 2013;15:557–570. doi: 10.1016/j.jcyt.2013.01.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jcyt.2013.01.005</ArticleId>
            <ArticleId IdType="pubmed">23388582</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zuk P.A., Zhu M., Ashjian P., De Ugarte D.A., Huang J.I., Mizuno H., Alfonso Z.C., Fraser J.K., Benhaim P., Hedrick M.H. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell. 2002;13:4279–4295. doi: 10.1091/mbc.e02-02-0105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1091/mbc.e02-02-0105</ArticleId>
            <ArticleId IdType="pmc">PMC138633</ArticleId>
            <ArticleId IdType="pubmed">12475952</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bharadwaj S., Liu G., Shi Y., Wu R., Yang B., He T., Fan Y., Lu X., Zhou X., Liu H., et al.  Multipotential differentiation of human urine-derived stem cells: Potential for therapeutic applications in urology. Stem Cells. 2013;31:1840–1856. doi: 10.1002/stem.1424.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/stem.1424</ArticleId>
            <ArticleId IdType="pubmed">23666768</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen L., Li L., Xing F., Peng J., Peng K., Wang Y., Xiang Z. Human Urine-Derived Stem Cells: Potential for Cell-Based Therapy of Cartilage Defects. Stem Cells Int. 2018;2018:4686259. doi: 10.1155/2018/4686259.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2018/4686259</ArticleId>
            <ArticleId IdType="pmc">PMC5932456</ArticleId>
            <ArticleId IdType="pubmed">29765413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu D., Cheng F., Pan S., Liu Z. Stem cells: A potential treatment option for kidney diseases. Stem Cell Res. Ther. 2020;11:249. doi: 10.1186/s13287-020-01751-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13287-020-01751-2</ArticleId>
            <ArticleId IdType="pmc">PMC7318741</ArticleId>
            <ArticleId IdType="pubmed">32586408</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qin D., Long T., Deng J., Zhang Y. Urine-derived stem cells for potential use in bladder repair. Stem Cell Res. Ther. 2014;5:69. doi: 10.1186/scrt458.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/scrt458</ArticleId>
            <ArticleId IdType="pmc">PMC4055102</ArticleId>
            <ArticleId IdType="pubmed">25157812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ikedo H., Tamaki K., Ueda S., Kato S., Fujii M., Ten Dijke P., Okuda S. Smad protein and TGF-beta signaling in vascular smooth muscle cells. Int. J. Mol. Med. 2003;11:645–650.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12684705</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang X., Long L., Southwood M., Rudarakanchana N., Upton P.D., Jeffery T.K., Atkinson C., Chen H., Trembath R.C., Morrell N.W. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension. Circ. Res. 2005;96:1053–1063. doi: 10.1161/01.RES.0000166926.54293.68.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.RES.0000166926.54293.68</ArticleId>
            <ArticleId IdType="pubmed">15845886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo X., Chen S.-Y. Transforming growth factor-β and smooth muscle differentiation. World J. Biol. Chem. 2012;3:41–52. doi: 10.4331/wjbc.v3.i3.41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4331/wjbc.v3.i3.41</ArticleId>
            <ArticleId IdType="pmc">PMC3312200</ArticleId>
            <ArticleId IdType="pubmed">22451850</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Owens G.K., Wise G. Regulation of differentiation/maturation in vascular smooth muscle cells by hormones and growth factors. Agents Actions Suppl. 1997;48:3–24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9177097</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chi J.-T., Rodriguez E.H., Wang Z., Nuyten D.S.A., Mukherjee S., van de Rijn M., van de Vijver M.J., Hastie T., Brown P.O. Gene expression programs of human smooth muscle cells: Tissue-specific differentiation and prognostic significance in breast cancers. PLoS Genet. 2007;3:1770–1784. doi: 10.1371/journal.pgen.0030164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pgen.0030164</ArticleId>
            <ArticleId IdType="pmc">PMC1994710</ArticleId>
            <ArticleId IdType="pubmed">17907811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tamama K., Sen C.K., Wells A. Differentiation of bone marrow mesenchymal stem cells into the smooth muscle lineage by blocking ERK/MAPK signaling pathway. Stem Cells Dev. 2008;17:897–908. doi: 10.1089/scd.2007.0155.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/scd.2007.0155</ArticleId>
            <ArticleId IdType="pmc">PMC2973839</ArticleId>
            <ArticleId IdType="pubmed">18564029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Narita Y., Yamawaki A., Kagami H., Ueda M., Ueda Y. Effects of transforming growth factor-beta 1 and ascorbic acid on differentiation of human bone-marrow-derived mesenchymal stem cells into smooth muscle cell lineage. Cell Tissue Res. 2008;333:449–459. doi: 10.1007/s00441-008-0654-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00441-008-0654-0</ArticleId>
            <ArticleId IdType="pubmed">18607632</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park J.S., Chu J.S., Tsou A.D., Diop R., Tang Z., Wang A., Li S. The effect of matrix stiffness on the differentiation of mesenchymal stem cells in response to TGF-β. Biomaterials. 2011;32:3921–3930. doi: 10.1016/j.biomaterials.2011.02.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biomaterials.2011.02.019</ArticleId>
            <ArticleId IdType="pmc">PMC3073995</ArticleId>
            <ArticleId IdType="pubmed">21397942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biswas B., Bhattacharyya A., Dasgupta A., Karmakar A., Mallick N., Sembiah S. Urinary Incontinence, Its Risk Factors, and Quality of Life: A Study among Women Aged 50 Years and above in a Rural Health Facility of West Bengal. J. Midlife Health. 2017;8:130–136. doi: 10.4103/jmh.JMH_62_17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/jmh.JMH_62_17</ArticleId>
            <ArticleId IdType="pmc">PMC5625577</ArticleId>
            <ArticleId IdType="pubmed">28983160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang H.H., Salcedo L.B., Damaser M.S. Quantification of neurological and other contributors to continence in female rats. Brain Res. 2011;1382:198–205. doi: 10.1016/j.brainres.2011.01.094.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.brainres.2011.01.094</ArticleId>
            <ArticleId IdType="pmc">PMC3082282</ArticleId>
            <ArticleId IdType="pubmed">21295013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lightner D.J., Knoedler J.J., Linder B.J.  Periurethral Bulking Agent Injection in the Treatment of Female Stress Urinary Incontinence. In: Goldman H.B., editor. Complications of Female Incontinence and Pelvic Reconstructive Surgery. Springer International Publishing; Cham, Switzerland: 2017. pp. 297–305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-3-319-49855-3_27</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ni J., Li H., Zhou Y., Gu B., Xu Y., Fu Q., Peng X., Cao N., Fu Q., Jin M., et al.  Therapeutic Potential of Human Adipose-Derived Stem Cell Exosomes in Stress Urinary Incontinence—An in Vitro and in Vivo Study. Cell. Physiol. Biochem. 2018;48:1710–1722. doi: 10.1159/000492298.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000492298</ArticleId>
            <ArticleId IdType="pubmed">30077997</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zambon J.P., Williams K.J. Applicability of regenerative medicine and tissue engineering for the treatment of stress urinary incontinence in female patients. Neurourol. Urodyn. 2019;38((Suppl. 4)):S76–S83. doi: 10.1002/nau.24033.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/nau.24033</ArticleId>
            <ArticleId IdType="pubmed">31099087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peyromaure M., Sebe P., Praud C., DeRocle G., Potin N., Pinset C., Sebille A. Fate of implanted syngenic muscle precursor cells in striated urethral sphincter of female rats: Perspectives for treatment of urinary incontinence. Urology. 2004;64:1037–1041. doi: 10.1016/j.urology.2004.06.058.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.urology.2004.06.058</ArticleId>
            <ArticleId IdType="pubmed">15533514</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z., Wen Y., Li Y.H., Wei Y., Green M., Wani P., Zhang P., Pera R.R., Chen B. Smooth Muscle Precursor Cells Derived from Human Pluripotent Stem Cells for Treatment of Stress Urinary Incontinence. Stem Cells Dev. 2016;25:453–461. doi: 10.1089/scd.2015.0343.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/scd.2015.0343</ArticleId>
            <ArticleId IdType="pmc">PMC4818543</ArticleId>
            <ArticleId IdType="pubmed">26785911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abbas T.O., Ali T.A., Uddin S. Urine as a Main Effector in Urological Tissue Engineering—A Double-Edged Sword. Cells. 2020;9:538.  doi: 10.3390/cells9030538.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cells9030538</ArticleId>
            <ArticleId IdType="pmc">PMC7140397</ArticleId>
            <ArticleId IdType="pubmed">32110928</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bharadwaj S., Liu G., Shi Y., Markert C., Andersson K.-E., Atala A., Zhang Y. Characterization of Urine-Derived Stem Cells Obtained from Upper Urinary Tract for Use in Cell-Based Urological Tissue Engineering. Tissue Eng. Part A. 2011;17:2123–2132. doi: 10.1089/ten.tea.2010.0637.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ten.tea.2010.0637</ArticleId>
            <ArticleId IdType="pubmed">21513463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sinha S., Hoofnagle M.H., Kingston P.A., McCanna M.E., Owens G.K. Transforming growth factor-β1 signaling contributes to development of smooth muscle cells from embryonic stem cells. Am. J. Physiol.-Cell Physiol. 2004;287:C1560–C1568. doi: 10.1152/ajpcell.00221.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpcell.00221.2004</ArticleId>
            <ArticleId IdType="pubmed">15306544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Owens G.K., Kumar M.S., Wamhoff B.R. Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease. Physiol. Rev. 2004;84:767–801. doi: 10.1152/physrev.00041.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/physrev.00041.2003</ArticleId>
            <ArticleId IdType="pubmed">15269336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Desmoulière A., Geinoz A., Gabbiani F., Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 1993;122:103–111. doi: 10.1083/jcb.122.1.103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.122.1.103</ArticleId>
            <ArticleId IdType="pmc">PMC2119614</ArticleId>
            <ArticleId IdType="pubmed">8314838</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Woodman L., Siddiqui S., Cruse G., Sutcliffe A., Saunders R., Kaur D., Bradding P., Brightling C. Mast Cells Promote Airway Smooth Muscle Cell Differentiation via Autocrine Up-Regulation of TGF-β1. J. Immunol. 2008;181:5001–5007. doi: 10.4049/jimmunol.181.7.5001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.181.7.5001</ArticleId>
            <ArticleId IdType="pmc">PMC3992381</ArticleId>
            <ArticleId IdType="pubmed">18802103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sibov T.T., Severino P., Marti L.C., Pavon L.F., Oliveira D.M., Tobo P.R., Campos A.H., Paes A.T., Amaro E., Jr., Gamarra L.F., et al.  Mesenchymal stem cells from umbilical cord blood: Parameters for isolation, characterization and adipogenic differentiation. Cytotechnology. 2012;64:511–521. doi: 10.1007/s10616-012-9428-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10616-012-9428-3</ArticleId>
            <ArticleId IdType="pmc">PMC3432537</ArticleId>
            <ArticleId IdType="pubmed">22328147</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moraes D.A., Sibov T.T., Pavon L.F., Alvim P.Q., Bonadio R.S., Da Silva J.R., Pic-Taylor A., Toledo O.A., Marti L.C., Azevedo R.B., et al.  A reduction in CD90 (THY-1) expression results in increased differentiation of mesenchymal stromal cells. Stem Cell Res. Ther. 2016;7:97. doi: 10.1186/s13287-016-0359-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13287-016-0359-3</ArticleId>
            <ArticleId IdType="pmc">PMC4964048</ArticleId>
            <ArticleId IdType="pubmed">27465541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Long X., Bell R.D., Gerthoffer W.T., Zlokovic B.V., Miano J.M. Myocardin is sufficient for a smooth muscle-like contractile phenotype. Arterioscler. Thromb. Vasc. Biol. 2008;28:1505–1510. doi: 10.1161/ATVBAHA.108.166066.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/ATVBAHA.108.166066</ArticleId>
            <ArticleId IdType="pmc">PMC2574857</ArticleId>
            <ArticleId IdType="pubmed">18451334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang D.Z., Olson E.N. Control of smooth muscle development by the myocardin family of transcriptional coactivators. Curr. Opin. Genet. Dev. 2004;14:558–566. doi: 10.1016/j.gde.2004.08.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.gde.2004.08.003</ArticleId>
            <ArticleId IdType="pubmed">15380248</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Z.-P., Wang Z., Yanagisawa H., Olson E.N. Phenotypic Modulation of Smooth Muscle Cells through Interaction of Foxo4 and Myocardin. Dev. Cell. 2005;9:261–270. doi: 10.1016/j.devcel.2005.05.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2005.05.017</ArticleId>
            <ArticleId IdType="pubmed">16054032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Veber M., Dolivo D., Rolle M., Dominko T. Pro-myogenic and low-oxygen culture increases expression of contractile smooth muscle markers in human fibroblasts. J. Tissue Eng. Regen. Med. 2018;12:572–582. doi: 10.1002/term.2473.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/term.2473</ArticleId>
            <ArticleId IdType="pubmed">28513058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hwang Y., Cha S.-H., Hong Y., Jung A.R., Jun H.-S. Direct differentiation of insulin-producing cells from human urine-derived stem cells. Int. J. Med. Sci. 2019;16:1668–1676. doi: 10.7150/ijms.36011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7150/ijms.36011</ArticleId>
            <ArticleId IdType="pmc">PMC6909801</ArticleId>
            <ArticleId IdType="pubmed">31839754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang L., Qiu P., Jiao J., Hirai H., Xiong W., Zhang J., Zhu T., Ma P.X., Chen Y.E., Yang B. Yes-Associated Protein Inhibits Transcription of Myocardin and Attenuates Differentiation of Vascular Smooth Muscle Cell from Cardiovascular Progenitor Cell Lineage. Stem Cells. 2017;35:351–361. doi: 10.1002/stem.2484.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/stem.2484</ArticleId>
            <ArticleId IdType="pmc">PMC5984619</ArticleId>
            <ArticleId IdType="pubmed">27571517</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
